Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model. (2019)
Attributed to:
Targeting ERK and mTOR for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1523/eneuro.0097-19.2019
PubMed Identifier: 31147392
Publication URI: http://europepmc.org/abstract/MED/31147392
Type: Journal Article/Review
Volume: 6
Parent Publication: eNeuro
Issue: 3
ISSN: 2373-2822